International Journal of Neonatal Screening — Journal Editorial Boards


Dr. Ralph Fingerhut
Swiss Newborn Screening Laboratory, Steinwiesstr. 75, CH-8032 Zurich, Switzerland
Website | E-Mail
Interests: neonatal screening; process quality; knowledge scharing and education; new technologies in NBS; new applications in NBS; multiparameter analysis
Dr. Peter C.J.I. Schielen
Associate Editor
Reference Laboratory for Neonatal Screening, Centre for Infectious Diseases Research, Diagnostics and Sceening-IDS, National Institute of Public Health and the Environment – RIVM, NL-3720 BA Bilthoven, The Netherlands
Website | E-Mail
Interests: analytical assurance; inherited metabolic diseases; genomics; Laboratory information systems; galactosemia; SCID; LSDs cystic fibrosis; next generation sequencing in NBS
Special Issues and Collections in MDPI journals

Advisory Board

em. Prof. Dr. Adelbert A. Roscher
Lindwurmstr. 4 80337 München Bayern Germany
Prof. Dr. Harvey L. Levy
Professor of Pediatrics, Harvard Medical School; Division of Genetics and Genomics, Boston Children’s Hospital, 1 Autumn St., Boston, MA 02115, USA
Website | E-Mail
Interests: neonatal screening; inborn errors of metabolism; phenylketonuria; homocystinuria; galactosemia; endocrine disorders; program development; bio banking; assistance to developing countries in setting up/expanding NBS; biological anthropology; genetic epidemiology
Special Issues and Collections in MDPI journals:
Special Issue: Newborn Screening-Past, Present and Future
Dr. Victor R. De Jesus
Newborn Screening and Molecular Biology Branch US Centers for Disease Control and Prevention, USA
Interests: quality assurance; mass spectrometry; newborn screening; dried blood spot technologies
Dr. W. Harry Hannon
Independent Consultant on Newborn Screening, 4929 Duncans Lake Point, Buford, GA 30519, USA
Dr. Bradford L. Therrell
Nat. Newborn Screening Global Research Center 3907 Galaxia Drive Austin, TX 78759, USA
Website | E-Mail
Interests: inborn errors of metabolism and hemoglobinopathies; laboratory certification; and international laboratory guidelines and standards for newborn screening
Prof. Dr. Bridget Wilcken, AM, MD, FRACP, FRCPA (hon)
Senior Staff Physician, Genetic Metabolic Service, Sydney Children’s Hospital Randwick; Honorary Consultant, NSW Biochemical Genetics and Newborn Screening Services, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Dr. Enzo Ranieri
South Australian Neonatal Screening Centre, Directorate of Genetic and Molecular Pathology Women’s and Children’s Hospital Campus, Adelaide SA Pathology, South Australia, Australia

Editorial Board

Prof. Dr. Jim R. Bonham
Department of Clinical Chemistry, Sheffield Childrens NHS Foundation Trust, Sheffield, S10 2TH, UK
Interests: Quality assurance; Inherited metabolic disorders; Genomics; IT supporting patients; System governance
Dr. Gustavo JC Borrajo *
Detección de Errores Congénitos, Fundación Bioquímica Argentina, Calle 6 # 1344, 1900, La Plata, Argentina
Interests: newborn screening, with emphasis on analytical and quality assurance issues. PKU, CH, Cystic Fibrosis, Galactosemia, CAH, Biotinidase Deficiency, MSUD and Tandem Mass Spectrometry. Assistance to Latin American countries in setting up newborn screening activities
* Region Latin America
Prof. Dr. Regina Ensenauer
Division of Experimental Pediatrics & Metabolism University Children’s Hospital Heinrich Heine University Düsseldorf, Germany
Website | E-Mail
Interests: newborn metabolic screening, metabolism, metabolite profiling, early origins of childhood obesity & associated metabolic disease, fetal metabolic programming, nutrient-sensing mechanisms, metabolic & nutritional medicine
Dr. Can Ficicioglu
Perelman School of Medicine, University of Pennsylvania; Division of Human Genetics,Section of Metabolic disorders, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA
Website | E-Mail
Interests: PKU; galactosemia; fatty acid oxidation defects; cobalamin disorders; homocystinuria; MPS II; LAL deficiency and organic acidopathies
Special Issues and Collections in MDPI journals:
Special Issue: New Developments in Biomarkers and Therapies for Inborn Errors of Metabolism
Dr. Mária Knapková *
Children´s University Hospital, Banska Bystrica, Slovakia: Newborn Screening Centre Slovak Republic, Laboratory Manager, Slovakia
Website | E-Mail
Interests: cystic fibrosis; CH; PKU; CAH; fatty acid oxidation defects; carnitine deficiency
* Region Europe
Dr. Rasoul Alikhani Koupaei, DCC, FCACB, DABCC, FACB
Chief, Genetic Disease Laboratory Branch, CA Department of Public Health, 850 Marina Bay Parkway, G272 Richmond, CA 94804, USA
Dr. Fred Lorey *
Former Director, CA Newborn Screening Program; HHS Advisory Committee on Heritable Disorders; Advisory board for Save Babies through Screening and Human Longevity, Inc., Pleasant Hill, CA, USA
Interests: SCID; hemoglobinopathies; metabolic disorders; endocrine disorders; program development; bio banking; assistance to developing countries in setting up/expanding NBS; biological anthropology; genetic epidemiology
* Region North America
Dr. James Pitt
Metabolic and Newborn Screening Laboratories, Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, Melbourne, Australia
Website | E-Mail
Interests: inborn errors of metabolism; newborn screening; mass spectrometry; metabolomics
Prof. Dr. Amal Saadallah *
Newborn Screening and Biochemical Genetics Laboratory (NLNBS), King Faisal Specialist Hospital & Research Center, MBC-03-30, Riyad 11211, Saudi Arabia
* Region Middle East & North Africa
Back to Top